昭衍新药
(603127)
| 流通市值：114.05亿 | | | 总市值：135.65亿 |
| 流通股本：6.30亿 | | | 总股本：7.50亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2024-05-07 | -3854.59万 | -6.38% | -1698.18万 | -2.81% | -100.24万 | -0.17% | 5653.01万 | 9.36% |
| 2024-05-06 | 6758.61万 | 9.41% | 2655.06万 | 3.69% | -3376.45万 | -4.70% | -6037.22万 | -8.40% |
| 2024-04-30 | -3772.90万 | -6.63% | -2094.70万 | -3.68% | 114.07万 | 0.20% | 5753.54万 | 10.11% |
| 2024-04-29 | 1400.00万 | 3.80% | -343.61万 | -0.93% | -2985.98万 | -8.10% | 1929.60万 | 5.24% |
| 2024-04-26 | -606.53万 | -1.88% | -3247.02万 | -10.07% | -1163.08万 | -3.61% | 5016.63万 | 15.56% |
| 2024-04-25 | -162.70万 | -0.81% | 673.05万 | 3.34% | -745.47万 | -3.70% | 235.12万 | 1.17% |
| 2024-04-24 | -213.88万 | -0.96% | -1493.34万 | -6.71% | 254.42万 | 1.14% | 1452.80万 | 6.52% |
| 2024-04-23 | 248.66万 | 0.88% | 891.73万 | 3.16% | 970.55万 | 3.44% | -2110.94万 | -7.49% |
| 2024-04-22 | -100.70万 | -0.66% | 128.52万 | 0.84% | -255.27万 | -1.67% | 227.45万 | 1.49% |
| 2024-04-19 | -256.64万 | -1.20% | -1752.06万 | -8.22% | -47.96万 | -0.22% | 2056.66万 | 9.65% |